Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03808129
Other study ID # P0001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 18, 2019
Est. completion date April 20, 2019

Study information

Verified date March 2020
Source Bezmialem Vakif University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Brief summary: Regional anesthesia decreases the need for intravenous analgesia in the peri-operative period. Erector spinae plane (ESP) is a regional anesthesia technique shown to be effective at the dorsal and ventral rami of the thoracic spinal nerve along with sympathetic nerve fibers. The purpose is to demonstrate the contribution of ESP block to the postoperative analgesia by ultrasonography and to increase intraabdominal tissue oxygenation compared to the control group.


Description:

50 patients with American Society of Anesthesiologists (ASA) physical score I-II were randomly divided into 25 patients in the ESP group and 25 patients in the control group. Patients were premedicated with oral midazolam 0.5 mg kg-1, 30 minutes before surgery Anesthesia monitorization was made with electrocardiogram, non-invasive blood pressure, peripheral oxygen saturation (SpO2), end-tidal carbon dioxide, temperature, Bispectral index (BIS), and Regional tissue saturation (rSO2). Anesthesia was induced with a face mask distributing 8% sevoflurane and 50% air in oxygen while the patients were breathing spontaneously. After anesthesia induction, peripheral venous access was established and propofol 2 mg kg-1 and fentanyl citrate 1 μg kg-1 were administered. Laryngeal mask airways were used to secure the upper airways. Anesthesia was maintained with sevoflurane and 50% air in oxygen. The concentration of sevoflurane was adjusted by targeting BIS scores at 50-60 in all groups. During the operations, fentanyl was administered at a dose of 0.5 μg kg-1 if the blood pressure and heart rates were 20% higher than the baseline value. In ESP blok groups, after general anesthesia induced, patients were placed in the lateral position and ESP block was performed under ultrasound guidance. For ESP block, 1: 1 ratio of 0.25% bupivacaine and 0.4 ml / kg of 1% lidocaine was administered. In all groups, regional tissue saturation (RSO2) was evaluated Continuously with near infrared spectroscopy (NIRS) probe from anesthesia induction to the end of surgery. Commercially available device (INVOS Cerebral Oximeter; somatics Corp, Troy, Mich) was used to monitor rSO2 values in the surgery side flank during surgical intervention. Pain was evaluated and recorded using the FLACC (Face, Legs, Activity, Cry, Consolability) scale at the 1st, 2nd, 8th, 12th and 24th hours. Total analgesic consumption was recorded during the operation and postoperative time to first analgesic drug and number of patients who required analgesic in the first 24 hours, parents satisfaction score, discharge time as well as adverse effects such as nausea and vomiting were recorded in the postoperative periods.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date April 20, 2019
Est. primary completion date April 12, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 2 Years
Eligibility Inclusion Criteria:

1. Children aged 6 months to 2 years

2. According to American Anesthesia Society Anesthesia Risk Scale ASA I-II class patients

3. Patients with lower abdominal surgery

Exclusion Criteria:

1. Children under 6 months and older than 2 years

2. According to American Anesthesia Society Anesthesia Risk Scale Patients with ASA III-IV class

3. Patients with contraindication to regional anesthesia

4. Patients with a history of local anesthetic allergy

5. Patients with abnormal coagulation profile

6. Patients with infection at the injection site

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bupivacaine and Lidocaine
ESP block was administered under general anesthesia before the surgery. Patients with ESP block, 1: 1 ratio of 0.25% bupivacaine and 0.4 ml / kg of 1% lidocaine

Locations

Country Name City State
Turkey Parvin Pinar Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary FLACC scale FLACC scale was used. The Face, Legs, Activity, Cry, Consolability scale (FLACC) scale was a measurement used to assess pain for children between the ages of 6 months and 2 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2. From recovery of anesthesia to end of study ( postoperative 24 hours)
Primary NIRS INVOS ;Somatic Corp, Troy, Mic sensors placed in surgical side of patients was used to detect peripheral perfusion and oxygen delivery (rSo2) Before anesthesia induction to end of operation ( intraoperative 2 hours )
Secondary Time to first analgesic drug Time to first analgesic drug will be recorded first 24 hour
Secondary Need for analgesic Number of patients who required analgesic in the first 24 hour first 24 hour
See also
  Status Clinical Trial Phase
Recruiting NCT03328481 - Quadratus Lumborum Block Using Loss-of-resistance Versus Ultrasound-guided Technique N/A
Withdrawn NCT04561414 - Objective to Evaluate the Safety and Effectiveness of LED Light Source System for Endoscopy in Ureteral Radiography N/A
Completed NCT06050044 - Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery N/A
Completed NCT02398123 - Transversus Abdominis Plane Versus Caudal Block for Pediatrics Phase 1
Recruiting NCT05524038 - Comparison Between the Quadratus Lumborum Block ,Erector Spinae Plane Block in Lower Abdominal Surgery N/A
Completed NCT05284734 - Comparison of Caudal Block and Erector Spinae Block for Postoperative Analgesia N/A